4.7 Article

Whole-exome analyses of congenital muscular dystrophy and congenital myopathy patients from India reveal a wide spectrum of known and novel mutations

期刊

EUROPEAN JOURNAL OF NEUROLOGY
卷 28, 期 3, 页码 992-1003

出版社

WILEY
DOI: 10.1111/ene.14616

关键词

congenital muscular dystrophy; congenital myopathy; mutation spectrum; neuromuscular diseases; phenotypic heterogeneity; whole‐ exome sequencing; genetic diagnosis

资金

  1. Agency for Science, Technology and Research (A*STAR) of Singapore [MR0406]
  2. Intramural Funds of National Institute of Biomedical Genomics, Kalyani, West Bengal, India

向作者/读者索取更多资源

This study aimed to genetically diagnose a cohort of 36 difficult-to-diagnose CMD and CM cases of Indian origin using whole-exome sequencing. Rare and deleterious mutations in previously reported CMD and CM-related genes were identified, and molecular dynamics studies revealed potential mechanisms of pathogenesis for certain mutations.
Background and purpose Congenital muscular dystrophies (CMDs) and congenital myopathies (CMs) are a group of genetically and clinically heterogeneous degenerative primary muscle disorders with onset at birth or during infancy. Due to vast heterogeneity, clinical examination and protein-based analyses often fail to identify the genetic causes of these diseases. The aim of this study was to genetically diagnose a cohort of 36 difficult-to-diagnose CMD and CM cases of Indian origin using next-generation sequencing methods. Methods Whole-exome sequencing (WES) was performed to identify pathogenic mutations in previously reported CMD and CM-related genes using variant calling and stringent variant filtration process. Subsequently, in silico homology modelling and molecular dynamics simulations (MDS) studies were undertaken for a number of novel and missense variants. Results A total of 33 and 21 rare and deleterious mutations were identified in 28 genes previously reported in CMD and CM based on OMIM, ClinVar and Orphanet, respectively. We could accurately diagnose 54% patients (n = 12/22) in the CMD group and 35% patients (n = 5/14) in the CM group. Furthermore, MDS studies for mutations located in LMNA, LAMA2 and RYR1 suggest that the wild-type proteins are more stable than their mutant counterparts, implying a potential mechanism of pathogenesis. Conclusion The WES findings led us to identify reported as well as novel variants for the first time in Indian patients with CMD and CM. This allowed us to achieve an accurate genetic diagnosis, which was difficult using conventional diagnostic tools. Transferring these WES findings to clinical practice will help guide clinical care of the affected patients and inform genetic counselling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据